Clinical Trial

Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates whether images taken using a photon counting detector CT scanner (PCD-CT) can determine the growth of rectal cancer as well as, or better than, MRI for the management of patients with rectal cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-01; most recent amendment 2026-04-17.
Trial Details
NCT Number NCT06965166
Lead Sponsor Mayo Clinic
Conditions Rectal Carcinoma
Enrollment 200 participants
Start Date 2024-10-07
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-22